Business Segment Information Level 3 (Tables)

9 Months Ended

Dec. 31, 2011

Notes To Financial Statements [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following tables:

	Three Months Ended December 31,						Nine Months Ended December 31,
	2011			2010			2011			2010
Revenues:
Healthcare (1)	$	259,055		$	237,843		$	725,455		$	561,723
Life Sciences	55,892			51,247			167,675			151,374
Isomedix	39,615			38,081			121,617			113,721
Total reportable segments	354,562			327,171			1,014,747			826,818
Corporate and other	653			1,112			1,814			2,870
Total revenues	$	355,215		$	328,283		$	1,016,561		$	829,688
Operating income (loss):
Healthcare (2) (3)	$	33,951		$	20,389		$	88,213		$	(19,460	)
Life Sciences	10,297			7,345			30,820			23,075
Isomedix	11,750			10,250			35,924			30,858
Total reportable segments	55,998			37,984			154,957			34,473
Corporate and other	(2,274		)	(2,153		)	(6,689		)	(6,735		)
Total operating income (loss)	$	53,724		$	35,831		$	148,268		$	27,738

(1) Includes a reduction of $102,313 resulting from the SYSTEM 1 Rebate Program in the nine months ended December 31, 2010.

(2) Includes a reduction of $110,004 resulting from the SYSTEM 1 Rebate Program in the nine months ended December 31, 2010.

(3) Includes a reduction of $19,796 resulting from a class action settlement in the three and nine month periods ended December 31, 2010.